Pharmaceutical Development of Eye Drops Using the Product Betamann® as an Example

Wawretschek, L.

doi:10.1007/978-3-7091-4067-3_9

L. Wawretschek²

42 Accesses

Abstract

It is the aim of this paper to provide a brief insight into the problems involved in the pharmaceutical development of an eye drop product, whereby Betamann is used as an example.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 39.99; Price excludes VAT (USA)

Softcover Book: USD 54.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Messrs. Dr. Mann Pharma, Brunsbütteler Damm 165-173, D-1000, Berlin 20, Germany
Dr. L. Wawretschek

Authors

Dr. L. Wawretschek
View author publications
You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

Isar — Technical University, Munich, Federal Republic of Germany
Hanns-Jürgen Merté (Director of the Eye Infirmary and Outpatient Eye Clinic rechts) (Director of the Eye Infirmary and Outpatient Eye Clinic rechts)

Rights and permissions

Reprints and permissions

Copyright information

About this paper

Cite this paper

Wawretschek, L. (1984). Pharmaceutical Development of Eye Drops Using the Product Betamann® as an Example. In: Merté, HJ. (eds) Metipranolol. Springer, Vienna. https://doi.org/10.1007/978-3-7091-4067-3_9

Download citation

DOI: https://doi.org/10.1007/978-3-7091-4067-3_9
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-81824-4
Online ISBN: 978-3-7091-4067-3
eBook Packages: Springer Book Archive

Publish with us

Policies and ethics